Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 2
2021 4
2022 1
2023 1
2024 2
2025 3
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
NOTCH1 signaling is dysregulated by loss of the deubiquitinase USP28 with del(11q), uncovering USP28 inhibition as novel therapeutic target in CLL.
Ehrmann AS, Quijada-Álamo M, Close V, Guo M, Carracoi V, Pérez-Carretero C, Corchete LA, Friedrich T, Giaimo BD, Yosifov DY, Bloehdorn J, Rodríguez-Sánchez A, Tausch E, Schneider C, Döhner H, Kietzmann T, Borggrefe T, Stilgenbauer S, Oswald F, Hernández-Rivas JM, Mertens D. Ehrmann AS, et al. Among authors: perez carretero c. Leukemia. 2025 Aug;39(8):1892-1904. doi: 10.1038/s41375-025-02632-4. Epub 2025 Jun 2. Leukemia. 2025. PMID: 40456839 Free PMC article.
SAMHD1 dysfunction impairs DNA damage response and increases sensitivity to PARP inhibition in chronic lymphocytic leukemia.
Rodríguez-Sánchez A, Quijada-Álamo M, Pérez-Carretero C, Herrero AB, Arroyo-Barea A, Dávila-Valls J, Rubio A, García de Coca A, Benito-Sánchez R, Rodríguez-Vicente AE, Hernández-Rivas JM, Hernández-Sánchez M. Rodríguez-Sánchez A, et al. Among authors: perez carretero c. Sci Rep. 2025 Mar 26;15(1):10446. doi: 10.1038/s41598-025-93629-7. Sci Rep. 2025. PMID: 40140468 Free PMC article.
The Five "Ws" of Frailty Assessment and Chronic Lymphocytic Leukemia: Who, What, Where, Why, and When.
González-Gascón-Y-Marín I, Ballesteros-Andrés M, Martínez-Flores S, Rodríguez-Vicente AE, Pérez-Carretero C, Quijada-Álamo M, Rodríguez-Sánchez A, Hernández-Rivas JÁ. González-Gascón-Y-Marín I, et al. Among authors: perez carretero c. Cancers (Basel). 2023 Sep 2;15(17):4391. doi: 10.3390/cancers15174391. Cancers (Basel). 2023. PMID: 37686667 Free PMC article. Review.
From Biomarkers to Models in the Changing Landscape of Chronic Lymphocytic Leukemia: Evolve or Become Extinct.
González-Gascón-Y-Marín I, Muñoz-Novas C, Rodríguez-Vicente AE, Quijada-Álamo M, Hernández-Sánchez M, Pérez-Carretero C, Ramos-Ascanio V, Hernández-Rivas JÁ. González-Gascón-Y-Marín I, et al. Among authors: perez carretero c. Cancers (Basel). 2021 Apr 8;13(8):1782. doi: 10.3390/cancers13081782. Cancers (Basel). 2021. PMID: 33917885 Free PMC article. Review.
REL overexpression and sustained NF-κB signaling associated with 2p gain induce resistance to BTK inhibitors in Chronic Lymphocytic Leukemia.
Dehgane L, Mallet E, Brasseur C, Krzisch D, Zeitouni W, Hitier C, Ayoub M, Dubois K, Pérez Carretero C, Roos-Weil D, Choquet S, Maloum K, Bravetti C, Armand M, Garnier D, Hernández-Rivas JM, Susin SA, Nguyen-Khac F, Chapiro E; French Innovative Leukemia Organization (FILO). Dehgane L, et al. Among authors: perez carretero c. Leukemia. 2026 Jan;40(1):188-198. doi: 10.1038/s41375-025-02818-w. Epub 2025 Dec 9. Leukemia. 2026. PMID: 41366531
Dissecting the role of TP53 alterations in del(11q) chronic lymphocytic leukemia.
Quijada-Álamo M, Pérez-Carretero C, Hernández-Sánchez M, Rodríguez-Vicente AE, Herrero AB, Hernández-Sánchez JM, Martín-Izquierdo M, Santos-Mínguez S, Del Rey M, González T, Rubio-Martínez A, García de Coca A, Dávila-Valls J, Hernández-Rivas JÁ, Parker H, Strefford JC, Benito R, Ordóñez JL, Hernández-Rivas JM. Quijada-Álamo M, et al. Among authors: perez carretero c. Clin Transl Med. 2021 Feb;11(2):e304. doi: 10.1002/ctm2.304. Clin Transl Med. 2021. PMID: 33634999 Free PMC article.
Biological significance of monoallelic and biallelic BIRC3 loss in del(11q) chronic lymphocytic leukemia progression.
Quijada-Álamo M, Hernández-Sánchez M, Rodríguez-Vicente AE, Pérez-Carretero C, Rodríguez-Sánchez A, Martín-Izquierdo M, Alonso-Pérez V, García-Tuñón I, Bastida JM, Vidal-Manceñido MJ, Galende J, Aguilar C, Queizán JA, González-Gascón Y Marín I, Hernández-Rivas JÁ, Benito R, Ordóñez JL, Hernández-Rivas JM. Quijada-Álamo M, et al. Among authors: perez carretero c. Blood Cancer J. 2021 Jul 9;11(7):127. doi: 10.1038/s41408-021-00520-5. Blood Cancer J. 2021. PMID: 34244476 Free PMC article.
TRAF3 alterations are frequent in del-3'IGH chronic lymphocytic leukemia patients and define a specific subgroup with adverse clinical features.
Pérez-Carretero C, Hernández-Sánchez M, González T, Quijada-Álamo M, Martín-Izquierdo M, Santos-Mínguez S, Miguel-García C, Vidal MJ, García-De-Coca A, Galende J, Pardal E, Aguilar C, Vargas-Pabón M, Dávila J, Gascón-Y-Marín I, Hernández-Rivas JÁ, Benito R, Hernández-Rivas JM, Rodríguez-Vicente AE. Pérez-Carretero C, et al. Am J Hematol. 2022 Jul;97(7):903-914. doi: 10.1002/ajh.26578. Epub 2022 May 9. Am J Hematol. 2022. PMID: 35472012 Free article.
Chronic lymphocytic leukemia patients with chromosome 6q deletion as the sole cytogenetic abnormality display a high frequency of RPS15 mutations and have a poor prognosis.
Pérez Carretero C, González T, Quijada Álamo M, Rigolin GM, Dubuc A, Villaverde Ramiro Á, Rodríguez-Sánchez A, Rubio A, Dávila J, Vidal MJ, González Gascón Y Marín I, Hernández-Rivas JÁ, Benito R, Volpe V, Davids MS, Abramson JS, Cuneo A, Dal Cin P, Rodríguez-Vicente AE, Hernández-Rivas JM. Pérez Carretero C, et al. Am J Hematol. 2024 Sep;99(9):1845-1848. doi: 10.1002/ajh.27421. Epub 2024 Jul 1. Am J Hematol. 2024. PMID: 38949404 Free article. No abstract available.
13 results